This trial compares two surgical procedures for preventing ovarian cancer in patients with genetic mutations.
1 Primary · 0 Secondary · Reporting Duration: From baseline to 6 months
Active Control
Experimental Treatment
374 Total Participants · 2 Treatment Groups
Primary Treatment: Quality-of-Life Assessment · No Placebo Group · N/A
Age 30 - 50 · Female Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: